Risperdal investigation expanding?
Executive Summary
The Department of Justice is understood to have issued another round of subpoenas in an investigation into Janssen and its marketing of the antipsychotic Risperdal, apparently seeking information from journal publishers. The company is among several firms contacted as part of an Office of Personnel Management investigation into psychiatric drugs (1"The Pink Sheet" March 29, 2004, p. 19)....